Cargando…

Eradication of Pseudomonas aeruginosa with inhaled colistin in adults with non-cystic fibrosis bronchiectasis

The persistent isolation of Pseudomonas aeruginosa in the airways of non-cystic fibrosis bronchiectasis (NCFB) patients is associated with a worsening of the symptoms, increase of exacerbations, poor quality of life and functional impairment. The objective of this study was the analysis of the eradi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blanco-Aparicio, Marina, Saleta Canosa, Jesús Luis, Valiño López, Paz, Martín Egaña, María Teresa, Vidal García, Iria, Montero Martínez, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724485/ https://www.ncbi.nlm.nih.gov/pubmed/31480862 http://dx.doi.org/10.1177/1479973119872513

Ejemplares similares

Eradication of Pseudomonas aeruginosa in cystic fibrosis patients with inhalation of dry powder tobramycin
por: Akkerman-Nijland, Anne M., et al.
Publicado: (2020)

The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis
por: Dhand, Rajiv
Publicado: (2018)

Eradication of Pseudomonas aeruginosa in adults with cystic fibrosis
por: Kenny, S L, et al.
Publicado: (2014)

Response to inhaled ceftazidime in patients with non‐cystic fibrosis bronchiectasis and chronic bronchial infection unrelated to Pseudomonas aeruginosa
por: Riveiro, Vanessa, et al.
Publicado: (2022)

Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung
por: Hilliam, Yasmin, et al.
Publicado: (2017)

Impact of concomitant nontuberculous mycobacteria and Pseudomonas aeruginosa isolates in non-cystic fibrosis bronchiectasis
por: Hsieh, Meng-Heng, et al.
Publicado: (2018)

Epidemiology and natural history of Pseudomonas aeruginosa airway infections in non-cystic fibrosis bronchiectasis
por: Woo, Taylor E., et al.
Publicado: (2018)

Pseudomonas aeruginosa isolation in patients with non-cystic fibrosis bronchiectasis: a retrospective study
por: Wang, Hong, et al.
Publicado: (2018)

Risk factors for Pseudomonas aeruginosa colonization in non-cystic fibrosis bronchiectasis and clinical implications
por: Kwok, Wang Chun, et al.
Publicado: (2021)

Isolation of and risk factors for airway infection with Pseudomonas aeruginosa in patients with non-cystic fibrosis bronchiectasis
por: Figueiredo, Mara Rúbia, et al.
Publicado: (2021)

Evidence of Inhaled Tobramycin in Non-Cystic Fibrosis Bronchiectasis
por: Vendrell, Montserrat, et al.
Publicado: (2015)

No benefit of longer eradication therapy of Pseudomonas aeruginosa primoinfections in pediatric cystic fibrosis
por: Claude, F., et al.
Publicado: (2019)

Omics-based tracking of Pseudomonas aeruginosa persistence in “eradicated” cystic fibrosis patients
por: Bartell, Jennifer A., et al.
Publicado: (2021)

The role of Psl in the failure to eradicate Pseudomonas aeruginosa biofilms in children with cystic fibrosis
por: Morris, Amanda J., et al.
Publicado: (2021)

Inhalation with Fucose and Galactose for Treatment of Pseudomonas Aeruginosa in Cystic Fibrosis Patients
por: Hauber, Hans-Peter, et al.
Publicado: (2008)

A case of failed eradication of cystic fibrosis-related sinus colonisation by Pseudomonas aeruginosa
por: Linnane, Barry, et al.
Publicado: (2015)

The emergence of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis patients on inhaled antibiotics
por: AbdulWahab, Atqah, et al.
Publicado: (2017)

Influence of Pseudomonas Aeruginosa on Exacerbation in Patients with Bronchiectasis
por: Chawla, Kiran, et al.
Publicado: (2015)

Effectiveness of a multistep Pseudomonas aeruginosa eradication treatment protocol in children with cystic fibrosis in Brazil
por: Riquena, Barbara, et al.
Publicado: (2020)

Healthcare Cost and Utilization before and after Diagnosis of Pseudomonas aeruginosa among Patients with Non-Cystic Fibrosis Bronchiectasis in the U.S.
por: Blanchette, Christopher M., et al.
Publicado: (2017)

Inhaled Colistimethate Sodium in the Management of Patients with Bronchiectasis Infected by Pseudomonas aeruginosa: A Narrative Review of Current Evidence
por: de la Rosa-Carrillo, David, et al.
Publicado: (2022)

Predicting factors for chronic colonization of Pseudomonas aeruginosa in bronchiectasis
por: Pieters, A., et al.
Publicado: (2019)

Pseudomonas aeruginosa aggregation and Psl expression in sputum is associated with antibiotic eradication failure in children with cystic fibrosis
por: Morris, Amanda J., et al.
Publicado: (2022)

Eradication of Burkholderia cepacia Using Inhaled Aztreonam Lysine in Two Patients with Bronchiectasis
por: Iglesias, A., et al.
Publicado: (2014)

Spotlight on inhaled ciprofloxacin and its potential in the treatment of non-cystic fibrosis bronchiectasis
por: Chorepsima, Stamatia, et al.
Publicado: (2018)

Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains
por: Varga, John J., et al.
Publicado: (2015)

Combined With Mefloquine, Resurrect Colistin Active in Colistin-Resistant Pseudomonas aeruginosa in vitro and in vivo
por: Zhang, Xiaodong, et al.
Publicado: (2021)

Plumbagin resurrect colistin susceptible against colistin-resistant Pseudomonas aeruginosa in vitro and in vivo
por: Wang, Yue, et al.
Publicado: (2022)

Resveratrol Increases Sensitivity of Clinical Colistin-Resistant Pseudomonas aeruginosa to Colistin In Vitro and In Vivo
por: Wang, Lingbo, et al.
Publicado: (2022)

Family case studies: absence of Pseudomonas aeruginosa transmission in bronchiectasis
por: Sobala, Ruth, et al.
Publicado: (2022)

Current and Emerging Inhaled Antibiotics for Chronic Pulmonary Pseudomonas aeruginosa and Staphylococcus aureus Infections in Cystic Fibrosis
por: Li, Danni, et al.
Publicado: (2023)

Risk of Development of Resistance in Patients with Non-Cystic Fibrosis Bronchiectasis Treated with Inhaled Antibiotics
por: Regan, Kate H., et al.
Publicado: (2018)

Inhaled antibiotics therapy for stable non-cystic fibrosis bronchiectasis: a meta-analysis
por: Xu, Meng-Jiao, et al.
Publicado: (2020)

Microevolution of Pseudomonas aeruginosa in cystic fibrosis lungs
por: Cramer, Nina, et al.
Publicado: (2014)

Feasibility study to inform the design of a randomised controlled trial to eradicate Pseudomonas aeruginosa infection in individuals with Cystic Fibrosis
por: Hickey, Helen R, et al.
Publicado: (2010)

Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial
por: Hewer, Simon C Langton, et al.
Publicado: (2020)

Predictive modeling of antibiotic eradication therapy success for new-onset Pseudomonas aeruginosa pulmonary infections in children with cystic fibrosis
por: Graña-Miraglia, Lucía, et al.
Publicado: (2023)

Emergence of colistin resistant Pseudomonas aeruginosa at Tabriz hospitals, Iran
por: Goli, Hamid Reza, et al.
Publicado: (2016)

Colistin Resistance of Pseudomonas aeruginosa Isolated from Snakes in Taiwan
por: Liu, Po-Yu, et al.
Publicado: (2017)

XDR-Pseudomonas aeruginosa Outside the ICU: Is There Still Place for Colistin?
por: Del Giacomo, Paola, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4utvtsli4cm8ohut1932n67gc8